Grace Therapeutics Inc. (ACST) at a glance

Grace Therapeutics Inc. (ACST) is a micro-cap Healthcare company. It trades at $2.2. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (21/100).

Price
$2.20
Market cap
$20.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.79 to $5.18
Vestovix Score50/ 100How this works
Value
58
Growth
50
Income
40
Safety
66
Momentum
21

Other Healthcare stocks

See all